Search clinical trials for: Insulin(Scilin M30_BAY81-9924)

Total 11 results

Bayer

Completed

To Evaluate Clinical Outcome and Injection Compliance of Scilin (SEAS)

Diabetes Mellitus, Type 2

China
AstraZeneca

Completed

A Study to Characterize Regimens of Basal Insulin Intensified With Either Symlin® or Rapid Acting Insulin in Patients With Type 2 Diabetes

Type 2 Diabetes Mellitus

United States
AstraZeneca
Juvenile Diabetes Research Foundation

Completed

Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

United States
Adocia

Completed

A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
Adocia

Completed

A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus

Type 1 Diabetes Mellitus

Germany
Albert Einstein College of Medicine
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia

Type 1 Diabetes

United States
National Cancer Institute (NCI)

Completed

Sulindac in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia

Tobacco Use Disorder | Precancerous Condition | Stage I Non-small Cell Lung Cancer

United States, Canada
National Cancer Institute (NCI)

Completed

Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia

Rectal Cancer | Colon Cancer | Precancerous Condition

United States
National Cancer Institute (NCI)

Completed

Sulindac in Preventing Melanoma in Healthy Participants Who Are at Increased Risk of Melanoma

Precancerous Condition

United States
National Cancer Institute (NCI)

Completed

Eflornithine and Sulindac in Preventing Colorectal Cancer in Patients With Colon Polyps

Precancerous Condition

United States
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Sulindac and Tamoxifen in Treating Patients With Desmoid Tumor

Desmoid Tumor

United States

3

Subscribe